Illumina

Illumina

Illumina are a global leader in genomics – an industry at the intersection of biology and technology.

-
Telephone: +44 (0)1799 532 300
Email:
Fax: +44 (0)1799 532 301
Address: Chesterford Research Park, Little Chesterford, Nr Saffron Walden
Postcode: CB10 1XL
Country: United Kingdom
Website: http://www.illumina.com
Membership type:Corporate 51+ (£1,000+VAT pa)

At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
 
lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.4 billion in 2013. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review.  As of August 2014, the company had a $24 billion market capitalization.

Illumina launches TruSight Tumor 170

The newest addition in Illumina's clinical cancer research portfolio aims to establish a standardized method for tumor profiling.

7 November 2016Read in full

Illumina announces preliminary revenue for first quarter of fiscal year 2016

Illumina, Inc. has announced estimated first quarter revenue of approximately $572 million, a 6% increase compared to $539 million in the first quarter of 2015 and 7% growth on a constant currency basis. This estimate, which is unaudited, is based on management's preliminary financial analysis.

19 April 2016Read in full

Illumina invests in new $100M venture fund

Illumina, Inc. has announced that it has committed to invest $100M in a new venture capital firm that is strategically aligned with Illumina’s vision to improve human health by unlocking the power of the genome.

15 April 2016Read in full

Illumina forms new company to enable early cancer detection via blood-based screening

Illumina, Inc has announced GRAIL, a new company formed to enable cancer screening from a simple blood test. Powered by Illumina sequencing technology, GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids in blood.

11 January 2016Read in full

Ground breaking ceremony at Granta Park

Ceremony marks start of Illumina’s new EMEA headquarters

Life Sciences Minister George Freeman MP attended BioMed Realty’s groundbreaking ceremony of the new 155,000 square foot pre-let laboratory building for Illumina at Granta Park, Cambridge, yesterday (Weds).

22 October 2015Read in full

Illumina signs agreement to acquire GenoLogics

(BUSINESS WIRE)--Illumina, Inc. announced it has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of industry-leading laboratory information management systems (LIMS) for life sciences organisations.

5 August 2015Read in full

Illumina introduces Illumina SeqLab

Illumina, Inc. has announced the launch of Illumina SeqLab, an integrated solution for customers with HiSeq X™ Systems to enable large-scale human whole-genome sequencing operations.

17 July 2015Read in full

Annoroad and Illumina co-develop NGS diagnostic system for reproductive health

Annoroad and Illumina, Inc. today announced they have entered into an agreement to jointly develop advanced clinical applications for reproductive health based on next-generation sequencing (NGS) technology. The collaboration signals the increasing importance of genomic applications to improve healthcare in China.

10 June 2015Read in full

Cloud Health launches full service capacity of the Illumina HiSeq X Ten sequencing system

Cloud Health will promote the application of genetic sequencing technologies for both public health and clinical research within China, using the most powerful whole-genome sequencing platform in the world.

23 April 2015Read in full

Products developed by Berry Genomics and Illumina serve Chinese clinical NIPT market

Berry Genomics NextSeq CN500 instrument and non-invasive prenatal testing reagent kit receives Chinese FDA premarket clearance.

1 April 2015Read in full

  1. 1
  2. 2
  3. 3
  4. 4
20/07/2017

Director, HR

Do you want to make a difference? Illumina’s mission is to improve human health by unlocking the power of the genome. If that in...

Location: Cambridge
Salary: Unspecified
More Info
20/07/2017

Regional Communications Manager

The Regional Communications Manager (EMEA) will be responsible for setting the employee communications strategy for Illumina’s E...

Location: Cambridge
Salary: Unspecified
More Info
20/07/2017

Research Associate (SBS Biochemistry Development)

Research Associate (SBS Biochemistry Development)

Location: Within 10 m of Cambridge
Salary: Unspecified
More Info
18/07/2017

Technology Liaison Manager – Illumina Laboratory Services (ILS)

Are you looking for an opportunity to apply this knowledge to come of the most exciting new applications of NGS technology – cli...

Location: Within 25 m of Cambridge
Salary: Unspecified
More Info
14/07/2017

Sales Support Specialist

Do you want to make a difference? Illumina’s mission is to improve human health by unlocking the power of the genome. If that in...

Location: Cambridge
Salary: Unspecified
More Info
11/07/2017

Service Support Specialist

Service Support Specialist

Location: Cambridge
Salary: Unspecified
More Info
29/06/2017

Accounts Apprenticeship

Start your career in accounts gaining valuable, relevant experience; study for a recognised qualification (i.e. AAT or ACCA) and...

Location: Within 10 m of Cambridge
Salary: Unspecified
More Info
19/06/2017

Contracts Analyst (Italian and Spanish)

Do you want to make a difference? Illumina’s mission is to improve human health by unlocking the power of the genome. If that in...

Location: Cambridge
Salary: Unspecified
More Info
19/06/2017

IT Apprentice

Do you want to make a difference? Illumina’s mission is to improve human health by unlocking the power of the genome. If that in...

Location: Cambridge
Salary: Unspecified
More Info
08/06/2017

Product Development Scientist (Assay)

Product Development Scientist (Assay)

Location: Within 10 m of Cambridge
Salary: Unspecified
More Info
  1. 1
  2. 2